Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | 1120 days ago
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

read more
Major European Markets Close Slightly Weak

Major European Markets Close Slightly Weak

The major European markets closed slightly down on Friday as investors assessed recent moves of the central banks and weighed the potential impact of tariffs. A bit of profit taking also contributed to the market's weak close.
RTTNews | 14h 16min ago
TSX Marches On, Hits Fresh Record High; Materials Stocks Rally

TSX Marches On, Hits Fresh Record High; Materials Stocks Rally

The Canadian market is up firmly in positive territory a little past noon on Friday, extending recent gains, thanks largely to strong buying in the materials sector. Energy stocks are struggling for support due to weak oil prices. The mood remains fairly bullish amid expectations the Bank of Canada and the Federal Reserve will announce further easing this year to boost growth.
RTTNews | 15h 22min ago
Bank Of Japan Holds Rate Steady; Plans To Lower ETF Holdings

Bank Of Japan Holds Rate Steady; Plans To Lower ETF Holdings

The Japanese central bank left its key interest rate unchanged on Friday, as expected, but surprised markets with a decision to reduce the holdings of its massive stock of exchange-traded funds, suggesting that the monetary policy normalization is underway. The Bank of Japan policy board, led by Governor Kazuo Ueda, voted 7-2 to hold the uncollateralized overnight call rate at around 0.5 percen
RTTNews | 18h 17min ago
Bay Street Likely To Open On Subdued Note

Bay Street Likely To Open On Subdued Note

Canadian shares may open on a somewhat subdued note on Friday with investors reacting to retail sales data, and looking to take some profits following recent gains.
RTTNews | 19h 2min ago
Pound Slides As UK Bond Yield Soars

Pound Slides As UK Bond Yield Soars

The British pound weakened against other major currencies in the European session on Friday, as long-dated UK bond yields rise sharply in response to increasing public sector borrowings in August.
RTTNews | 20h 46min ago